Historic Moment in Australia’s Energy Transition as Hazelwood Battery Energy Storage System is Commissioned 14-06-2023, 08:45

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26

Monaco Classic Week: Tradition and Future with Sir Robin Knox-Johnston at Yacht Club 11-09-2025, 19:17